MedPath
HSA Approval

LEDAGA Topical Gel 160 μg /g

SIN16986P

LEDAGA Topical Gel 160 μg /g

LEDAGA Topical Gel 160 μg /g

April 15, 2024

JUNIPER BIOLOGICS PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantJUNIPER BIOLOGICS PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

GEL

TOPICAL

Medical Information

L01AA05

chlormethine

Manufacturer Information

Juniper Biologics Pte Ltd.

University of Iowa Pharmaceuticals (UIP)

Active Ingredients

Chlormethine hydrochloride equivalent to Chlormethine

160 μg /g

Mechlorethamine

Documents

Package Inserts

Ledaga PI.pdf

Approved: April 15, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

LEDAGA Topical Gel 160 μg /g - HSA Approval | MedPath